ERCC1 and non-small cell lung carcinoma: Another study has shown that patients with ERCC1-negative advanced non-small-cell lung cancer had better progression-free survival and overall survival (OS, P = 0.030) compared to ERCC1-positive patients (P = 0.016; (7).